Angela Hansen
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.6MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $7.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 23, 2022 | NIH | SBIR Phase II Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy | $899K | WinSanTor, Inc. |
| Sep 1, 2021 | NIH | SBIR Phase II Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy | $1.1M | WinSanTor, Inc. |
| Mar 30, 2021 | NIH | SBIR Phase II Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | $985K | WinSanTor, Inc. |
| Sep 23, 2020 | NIH | STTR Phase I Development of a topical fixed-dose combination drug for peripheral neuropathic pain. | $699K | WinSanTor, Inc. |
| May 8, 2020 | NIH | SBIR Phase II Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | $996K | WinSanTor, Inc. |
| Apr 26, 2019 | NIH | SBIR Phase II Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | $1.0M | WinSanTor, Inc. |
| Jul 1, 2016 | NIH | SBIR Phase II Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy | $592K | WinSanTor, Inc. |
| Apr 4, 2016 | NIH | SBIR Phase II Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy | $300K | WinSanTor, Inc. |
| Jun 24, 2015 | NIH | SBIR Phase II Pre-Clinical Development of Topical Pirenzepine for Treating Diabetic Neuropathy | $987K | WinSanTor, Inc. |
1 patents as inventor
- US WinSanTor, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#124
Awards as PI#151
Patents#273
Companies
- WinSanTor, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.